Vera Therapeutics, Inc. Interest Expense
Vera Therapeutics, Inc. (VERA) reported Interest Expense of $1.91 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-08
- Vera Therapeutics, Inc. interest expense for the quarter ending 2024-06-30 was $1.91M, a 109.19% increase year-over-year.
- Vera Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $1.91M, a 118.08% increase year-over-year.
- Vera Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $1.06M, a 76.29% increase year-over-year.
- Vera Therapeutics, Inc. interest expense for the quarter ending 2023-09-30 was $943.00K, a 541.50% increase year-over-year.
- Vera Therapeutics, Inc. interest expense for fiscal 2023 was $3.79M, a 281.65% increase from fiscal 2022.
- Vera Therapeutics, Inc. interest expense for fiscal 2022 was $992.00K, a 4860.00% increase from fiscal 2021.
- Vera Therapeutics, Inc. interest expense for fiscal 2021 was $20.00K, a 87.95% decline from fiscal 2020.
- Vera Therapeutics, Inc. interest expense for fiscal 2020 was $166.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.91M 10-Q · filed 2024-08-08 | $3.82M 10-Q · filed 2024-08-08 | $4.87M derived: sum of 3 quarters · filed 2024-08-08 | $5.82M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $1.91M 10-Q · filed 2024-05-10 | $2.96M derived: sum of 2 quarters · filed 2024-05-10 | $3.90M derived: sum of 3 quarters · filed 2024-05-10 | $4.82M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.00M derived: sum of 2 quarters · filed 2024-03-27 | $2.91M derived: sum of 3 quarters · filed 2024-08-08 | $3.79M 10-K · filed 2024-03-27 |
| 2023-09-30 | $943.00K 10-Q · filed 2023-11-09 | $1.86M derived: sum of 2 quarters · filed 2024-08-08 | $2.73M 10-Q · filed 2023-11-09 | $3.33M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $914.00K 10-Q · filed 2024-08-08 | $1.79M 10-Q · filed 2024-08-08 | $2.39M derived: sum of 3 quarters · filed 2024-08-08 | $2.53M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $874.00K 10-Q · filed 2024-05-10 | $1.47M derived: sum of 2 quarters · filed 2024-05-10 | $1.62M derived: sum of 3 quarters · filed 2024-05-10 | $1.75M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $599.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $746.00K derived: sum of 2 quarters · filed 2024-03-27 | $874.00K derived: sum of 3 quarters · filed 2024-03-27 | $992.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $147.00K 10-Q · filed 2023-11-09 | $275.00K derived: sum of 2 quarters · filed 2023-11-09 | $393.00K 10-Q · filed 2023-11-09 | $413.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $128.00K 10-Q · filed 2023-08-10 | $246.00K 10-Q · filed 2023-08-10 | $266.00K derived: sum of 3 quarters · filed 2023-08-10 | $266.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $118.00K 10-Q · filed 2023-05-11 | $138.00K derived: sum of 2 quarters · filed 2023-05-11 | $138.00K derived: sum of 3 quarters · filed 2023-05-11 | $138.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $20.00K derived: sum of 2 quarters · filed 2023-03-28 | $20.00K derived: sum of 3 quarters · filed 2023-03-28 | $20.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $15.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $15.00K derived: sum of 3 quarters · filed 2022-08-10 | $79.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $15.00K derived: sum of 2 quarters · filed 2022-05-16 | $79.00K derived: sum of 3 quarters · filed 2022-05-16 | $142.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $79.00K derived: sum of 2 quarters · filed 2022-03-28 | $142.00K derived: sum of 3 quarters · filed 2022-03-28 | $166.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $64.00K 10-Q · filed 2021-11-10 | $127.00K derived: sum of 2 quarters · filed 2021-11-10 | $151.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $63.00K 10-Q · filed 2021-08-16 | $87.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $24.00K 10-Q · filed 2021-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |